This Medical News story features a Q&A with physician-scientist and entrepreneur Patrick Soon-Shiong, MD, discussing the ‘cancer moonshot’ and promising approaches in cancer immunotherapy.
To investigate human papillomavirus (HPV) vaccine dose-level protection, Herweijer and coauthors examined the association between quadrivalent HPV vaccination and first occurrence of condyloma in relation to vaccine dose using data from Swedish population-based health registers for 1 045 165 females.
This review summarizes advances in risk classification methods, imaging techniques, biomarkers for diagnosis, and treatments for prostate cancer.
This noninferiority trial compares human papillomavirus (HPV) type–specific antibody responses among girls and boys aged 9 to 14 years given 2 doses of HPV vaccine vs adolescent girls and young women aged 16 to 26 years given 3 doses.
You currently have no searches saved.